Statistics for Efficacy and safety of erythropoietin in a chronic model of inflammatory bowel disease
Total visits
| views | |
|---|---|
| Efficacy and safety of erythropoietin in a chronic model of inflammatory bowel disease | 51 |
Total visits per month
| views | |
|---|---|
| January 2025 | 2 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| Efficacy and safety of erythropoietin in a chronic model of inflammatory bowel disease.pdf(legacy) | 35 |
| Efficacy and safety of erythropoietin in a chronic model of inflammatory bowel disease.pdf | 6 |
| DISSERTAÄ«O_VERS«O DEFINITIVA_Hauria.pdf(legacy) | 1 |
| The meaning of lymphadenopathies during adjuvant durvalumab after chemoradiotherapy for lung cancer_thinking beyond disease progression.pdf(legacy) | 1 |
| Digital radiography detector performance.pdf(legacy) | 1 |
Top country views
| views | |
|---|---|
| China | 15 |
| Portugal | 13 |
| United States | 10 |
| India | 2 |
| Argentina | 1 |
| Brazil | 1 |
| Canada | 1 |
| Czechia | 1 |
| Mongolia | 1 |
| Netherlands | 1 |
| Romania | 1 |
| Russia | 1 |
| Singapore | 1 |